Editas Medicine (EDIT) - Turnaround story!

Editas Medicine (EDIT) - Turnaround story!

Gene editing stocks are rebounding! It is great time to buy beaten down stock like EDITAS with solid pipeline for a nice upside surprise! Rank PACB, EDIT, DTIL, FATE, SGMO, ARWR, NTLA, CRSP. BPMC, ALNY, MRNA